Tellen Bennett
Concepts (422)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 18 | 2026 | 441 | 5.170 |
Why?
| | Sepsis | 18 | 2026 | 641 | 4.460 |
Why?
| | Intensive Care Units, Pediatric | 25 | 2026 | 285 | 4.370 |
Why?
| | Intracranial Pressure | 9 | 2026 | 65 | 3.280 |
Why?
| | Brain Injuries | 9 | 2025 | 508 | 2.260 |
Why?
| | Shock, Septic | 12 | 2026 | 216 | 2.200 |
Why?
| | Machine Learning | 9 | 2026 | 587 | 2.190 |
Why?
| | Decision Support Systems, Clinical | 5 | 2026 | 265 | 2.130 |
Why?
| | Child | 86 | 2026 | 22657 | 2.010 |
Why?
| | Intracranial Hypertension | 5 | 2025 | 41 | 1.960 |
Why?
| | Hospital Mortality | 19 | 2026 | 1031 | 1.730 |
Why?
| | Critical Care | 7 | 2025 | 697 | 1.520 |
Why?
| | Critical Illness | 13 | 2026 | 892 | 1.470 |
Why?
| | Child, Preschool | 48 | 2026 | 11799 | 1.450 |
Why?
| | Infant | 45 | 2026 | 10039 | 1.430 |
Why?
| | Pediatrics | 6 | 2024 | 1115 | 1.350 |
Why?
| | Aftercare | 4 | 2024 | 224 | 1.310 |
Why?
| | Electronic Health Records | 11 | 2026 | 1177 | 1.300 |
Why?
| | Respiration, Artificial | 9 | 2026 | 708 | 1.260 |
Why?
| | Seizures | 3 | 2018 | 477 | 1.170 |
Why?
| | Severity of Illness Index | 7 | 2025 | 2925 | 1.150 |
Why?
| | Monitoring, Physiologic | 5 | 2026 | 289 | 1.150 |
Why?
| | Databases, Factual | 15 | 2023 | 1486 | 1.140 |
Why?
| | Humans | 137 | 2026 | 144957 | 1.130 |
Why?
| | Outpatients | 8 | 2025 | 443 | 1.100 |
Why?
| | Adolescent | 51 | 2026 | 22453 | 1.040 |
Why?
| | Retrospective Studies | 42 | 2026 | 17101 | 1.000 |
Why?
| | Blood Culture | 1 | 2025 | 25 | 0.890 |
Why?
| | Pneumonia, Bacterial | 1 | 2025 | 113 | 0.850 |
Why?
| | Multiple Organ Failure | 8 | 2024 | 124 | 0.850 |
Why?
| | Male | 70 | 2026 | 72406 | 0.820 |
Why?
| | Female | 74 | 2026 | 78376 | 0.810 |
Why?
| | Bacterial Infections | 2 | 2024 | 246 | 0.810 |
Why?
| | Recovery of Function | 3 | 2019 | 710 | 0.800 |
Why?
| | Bacteremia | 1 | 2025 | 221 | 0.750 |
Why?
| | Infant, Newborn | 20 | 2026 | 6434 | 0.730 |
Why?
| | Pneumonia | 2 | 2025 | 631 | 0.730 |
Why?
| | Connective Tissue Diseases | 1 | 2023 | 84 | 0.710 |
Why?
| | Hospitalization | 11 | 2026 | 2434 | 0.710 |
Why?
| | Glasgow Coma Scale | 7 | 2026 | 213 | 0.690 |
Why?
| | Forecasting | 3 | 2021 | 391 | 0.660 |
Why?
| | Trauma Severity Indices | 3 | 2017 | 112 | 0.630 |
Why?
| | Health Services Research | 2 | 2019 | 396 | 0.590 |
Why?
| | Adenosine Monophosphate | 3 | 2025 | 86 | 0.590 |
Why?
| | Patient Discharge | 10 | 2024 | 983 | 0.580 |
Why?
| | Disability Evaluation | 2 | 2018 | 310 | 0.580 |
Why?
| | Algorithms | 7 | 2025 | 1839 | 0.570 |
Why?
| | Alanine | 3 | 2025 | 171 | 0.570 |
Why?
| | Wounds and Injuries | 5 | 2019 | 957 | 0.570 |
Why?
| | Specialties, Surgical | 1 | 2019 | 82 | 0.550 |
Why?
| | Pandemics | 5 | 2023 | 1695 | 0.540 |
Why?
| | Tranexamic Acid | 1 | 2018 | 53 | 0.540 |
Why?
| | Phenotype | 10 | 2026 | 3164 | 0.540 |
Why?
| | Systemic Inflammatory Response Syndrome | 6 | 2024 | 96 | 0.540 |
Why?
| | Organ Dysfunction Scores | 6 | 2024 | 53 | 0.530 |
Why?
| | Prospective Studies | 14 | 2026 | 7997 | 0.530 |
Why?
| | Fluid Therapy | 2 | 2025 | 147 | 0.530 |
Why?
| | United States | 23 | 2026 | 15988 | 0.520 |
Why?
| | Hypothermia, Induced | 1 | 2018 | 96 | 0.520 |
Why?
| | Neurophysiological Monitoring | 1 | 2017 | 9 | 0.520 |
Why?
| | Child Health | 1 | 2019 | 157 | 0.510 |
Why?
| | Nurses | 1 | 2019 | 178 | 0.490 |
Why?
| | Neurosurgical Procedures | 2 | 2023 | 202 | 0.490 |
Why?
| | Computer Security | 2 | 2021 | 25 | 0.490 |
Why?
| | Cohort Studies | 14 | 2025 | 5965 | 0.480 |
Why?
| | Chronic Disease | 2 | 2022 | 1813 | 0.470 |
Why?
| | Health Status Indicators | 1 | 2016 | 166 | 0.470 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 359 | 0.470 |
Why?
| | Patient Readmission | 2 | 2018 | 759 | 0.440 |
Why?
| | Medical Record Linkage | 2 | 2015 | 68 | 0.430 |
Why?
| | Physicians | 1 | 2023 | 940 | 0.430 |
Why?
| | Antiviral Agents | 4 | 2025 | 768 | 0.430 |
Why?
| | Medical Records Systems, Computerized | 1 | 2015 | 95 | 0.430 |
Why?
| | Child, Hospitalized | 1 | 2015 | 55 | 0.430 |
Why?
| | Anticonvulsants | 1 | 2017 | 242 | 0.430 |
Why?
| | Spinal Injuries | 1 | 2015 | 58 | 0.420 |
Why?
| | Hypertension | 2 | 2022 | 1264 | 0.420 |
Why?
| | Mannitol | 2 | 2022 | 40 | 0.400 |
Why?
| | Electroencephalography | 1 | 2017 | 551 | 0.400 |
Why?
| | Models, Biological | 1 | 2021 | 1822 | 0.400 |
Why?
| | Saline Solution, Hypertonic | 2 | 2022 | 42 | 0.400 |
Why?
| | Cervical Vertebrae | 1 | 2015 | 158 | 0.400 |
Why?
| | Supervised Machine Learning | 3 | 2023 | 23 | 0.390 |
Why?
| | Acute Kidney Injury | 3 | 2026 | 866 | 0.380 |
Why?
| | Speech Therapy | 1 | 2013 | 21 | 0.380 |
Why?
| | Macrophage Activation Syndrome | 1 | 2012 | 22 | 0.380 |
Why?
| | Decision Support Techniques | 1 | 2017 | 456 | 0.380 |
Why?
| | Software | 1 | 2018 | 692 | 0.370 |
Why?
| | Antibodies, Monoclonal | 6 | 2025 | 1524 | 0.370 |
Why?
| | Arthritis, Juvenile | 1 | 2012 | 58 | 0.360 |
Why?
| | Physical Therapy Specialty | 1 | 2013 | 55 | 0.360 |
Why?
| | Injury Severity Score | 5 | 2018 | 600 | 0.350 |
Why?
| | Risk Factors | 11 | 2024 | 10792 | 0.350 |
Why?
| | Emergency Service, Hospital | 3 | 2021 | 2313 | 0.350 |
Why?
| | Ferritins | 1 | 2011 | 69 | 0.350 |
Why?
| | Antibodies, Neutralizing | 5 | 2025 | 341 | 0.340 |
Why?
| | Occupational Therapy | 1 | 2013 | 111 | 0.330 |
Why?
| | Cerebrovascular Circulation | 2 | 2025 | 280 | 0.330 |
Why?
| | Prognosis | 7 | 2025 | 4293 | 0.330 |
Why?
| | Brain | 2 | 2014 | 2941 | 0.320 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2010 | 50 | 0.320 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 557 | 0.320 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2012 | 239 | 0.320 |
Why?
| | Models, Statistical | 1 | 2014 | 682 | 0.310 |
Why?
| | Inpatients | 2 | 2022 | 546 | 0.310 |
Why?
| | Autistic Disorder | 2 | 2023 | 211 | 0.300 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 117 | 0.300 |
Why?
| | Tomography, X-Ray Computed | 3 | 2023 | 2738 | 0.290 |
Why?
| | Adult | 29 | 2025 | 40506 | 0.290 |
Why?
| | Length of Stay | 4 | 2023 | 1337 | 0.270 |
Why?
| | Blood Pressure | 3 | 2025 | 1769 | 0.270 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2010 | 279 | 0.260 |
Why?
| | Proteome | 2 | 2022 | 518 | 0.250 |
Why?
| | Infant Equipment | 1 | 2006 | 9 | 0.250 |
Why?
| | Protective Devices | 1 | 2006 | 29 | 0.250 |
Why?
| | Comorbidity | 2 | 2022 | 1660 | 0.240 |
Why?
| | Logistic Models | 6 | 2024 | 2119 | 0.240 |
Why?
| | Survival Rate | 4 | 2019 | 2092 | 0.240 |
Why?
| | Middle Aged | 18 | 2025 | 35928 | 0.240 |
Why?
| | Epidemiological Monitoring | 1 | 2026 | 69 | 0.230 |
Why?
| | Antibodies, Viral | 3 | 2024 | 672 | 0.230 |
Why?
| | ROC Curve | 4 | 2026 | 615 | 0.230 |
Why?
| | Vasoconstrictor Agents | 1 | 2026 | 144 | 0.230 |
Why?
| | Albumins | 1 | 2026 | 118 | 0.230 |
Why?
| | Accidents, Traffic | 2 | 2006 | 191 | 0.230 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2016 | 57 | 0.220 |
Why?
| | Employment | 2 | 2024 | 188 | 0.220 |
Why?
| | Transcriptome | 2 | 2022 | 1046 | 0.220 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2025 | 151 | 0.220 |
Why?
| | Disease Progression | 5 | 2023 | 2852 | 0.220 |
Why?
| | Patient Care | 1 | 2025 | 118 | 0.210 |
Why?
| | Arterial Pressure | 1 | 2025 | 136 | 0.210 |
Why?
| | Biological Science Disciplines | 1 | 2024 | 16 | 0.210 |
Why?
| | Knowledge Bases | 1 | 2024 | 28 | 0.210 |
Why?
| | Health Care Rationing | 1 | 2024 | 60 | 0.210 |
Why?
| | Lymphoma | 1 | 2026 | 233 | 0.210 |
Why?
| | Population Surveillance | 2 | 2026 | 485 | 0.210 |
Why?
| | Accelerometry | 1 | 2024 | 119 | 0.200 |
Why?
| | Pattern Recognition, Automated | 1 | 2024 | 74 | 0.200 |
Why?
| | Qualitative Research | 2 | 2023 | 1671 | 0.200 |
Why?
| | Aged | 13 | 2025 | 25947 | 0.200 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2021 | 383 | 0.200 |
Why?
| | Wearable Electronic Devices | 1 | 2024 | 63 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 3 | 2025 | 3869 | 0.200 |
Why?
| | Hemodynamics | 3 | 2026 | 1121 | 0.190 |
Why?
| | Risk Assessment | 5 | 2026 | 3676 | 0.190 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 62 | 0.190 |
Why?
| | Microscopy | 2 | 2021 | 156 | 0.190 |
Why?
| | Medical Oncology | 1 | 2026 | 332 | 0.190 |
Why?
| | Data Collection | 4 | 2022 | 635 | 0.190 |
Why?
| | Heart Failure | 3 | 2023 | 2323 | 0.180 |
Why?
| | Lower Extremity | 1 | 2006 | 438 | 0.180 |
Why?
| | Brain Diseases | 1 | 2023 | 153 | 0.180 |
Why?
| | Problem Behavior | 1 | 2023 | 102 | 0.180 |
Why?
| | Vital Signs | 1 | 2022 | 48 | 0.180 |
Why?
| | Blood Pressure Determination | 1 | 2022 | 144 | 0.170 |
Why?
| | Homeostasis | 1 | 2025 | 640 | 0.170 |
Why?
| | Blood | 1 | 2022 | 109 | 0.170 |
Why?
| | Mobile Applications | 1 | 2024 | 196 | 0.170 |
Why?
| | Myocarditis | 1 | 2022 | 102 | 0.170 |
Why?
| | Precision Medicine | 1 | 2026 | 458 | 0.170 |
Why?
| | Creatine | 1 | 2001 | 63 | 0.170 |
Why?
| | Ventricular Pressure | 1 | 2001 | 52 | 0.170 |
Why?
| | Quality of Life | 2 | 2024 | 3192 | 0.170 |
Why?
| | Appendicitis | 1 | 2023 | 148 | 0.170 |
Why?
| | Fractures, Bone | 1 | 2006 | 415 | 0.170 |
Why?
| | Computer Simulation | 1 | 2026 | 1026 | 0.170 |
Why?
| | Global Health | 1 | 2024 | 401 | 0.170 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 326 | 0.170 |
Why?
| | Age Distribution | 1 | 2022 | 403 | 0.170 |
Why?
| | Policy Making | 2 | 1998 | 82 | 0.170 |
Why?
| | Veins | 1 | 2001 | 68 | 0.170 |
Why?
| | Morbidity | 1 | 2022 | 323 | 0.170 |
Why?
| | Young Adult | 8 | 2024 | 14126 | 0.170 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 63 | 0.170 |
Why?
| | Survivors | 2 | 2022 | 520 | 0.160 |
Why?
| | Washington | 2 | 2011 | 147 | 0.160 |
Why?
| | Reproducibility of Results | 6 | 2024 | 3415 | 0.160 |
Why?
| | Propensity Score | 2 | 2026 | 367 | 0.160 |
Why?
| | Heart Arrest | 1 | 2025 | 407 | 0.160 |
Why?
| | Common Data Elements | 1 | 2020 | 17 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2022 | 249 | 0.160 |
Why?
| | Intersectoral Collaboration | 1 | 2021 | 62 | 0.160 |
Why?
| | Interferons | 1 | 2022 | 188 | 0.160 |
Why?
| | Physical Exertion | 1 | 2001 | 207 | 0.160 |
Why?
| | Focus Groups | 1 | 2023 | 573 | 0.160 |
Why?
| | Body Temperature | 1 | 2001 | 229 | 0.160 |
Why?
| | Monitoring, Ambulatory | 1 | 2001 | 89 | 0.160 |
Why?
| | Acute Lung Injury | 1 | 2023 | 303 | 0.160 |
Why?
| | Databases, Genetic | 1 | 2021 | 249 | 0.160 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2021 | 561 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2026 | 1990 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2024 | 367 | 0.150 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 372 | 0.150 |
Why?
| | Neurosurgeons | 1 | 2019 | 17 | 0.150 |
Why?
| | Hypoxia | 2 | 2024 | 1199 | 0.150 |
Why?
| | Acute Disease | 1 | 2022 | 1031 | 0.150 |
Why?
| | Dexamethasone | 1 | 2021 | 372 | 0.150 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2023 | 300 | 0.140 |
Why?
| | Datasets as Topic | 3 | 2026 | 122 | 0.140 |
Why?
| | Medicine | 1 | 2020 | 125 | 0.140 |
Why?
| | Terminology as Topic | 2 | 1998 | 255 | 0.140 |
Why?
| | Regression Analysis | 2 | 2017 | 1003 | 0.140 |
Why?
| | Information Dissemination | 1 | 2021 | 223 | 0.140 |
Why?
| | Journalism, Medical | 1 | 1998 | 4 | 0.140 |
Why?
| | Maternal Mortality | 1 | 1999 | 53 | 0.140 |
Why?
| | Social Determinants of Health | 1 | 2023 | 301 | 0.140 |
Why?
| | Abortion, Legal | 1 | 1999 | 28 | 0.140 |
Why?
| | Registries | 2 | 2018 | 2385 | 0.140 |
Why?
| | Critical Care Nursing | 1 | 2019 | 51 | 0.140 |
Why?
| | Biomarkers | 3 | 2025 | 4275 | 0.140 |
Why?
| | Programming Languages | 1 | 2018 | 25 | 0.140 |
Why?
| | Immunohistochemistry | 2 | 2020 | 1718 | 0.140 |
Why?
| | Proportional Hazards Models | 3 | 2025 | 1325 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5417 | 0.140 |
Why?
| | Maternal-Child Health Centers | 1 | 1997 | 8 | 0.140 |
Why?
| | National Health Programs | 1 | 1997 | 23 | 0.130 |
Why?
| | Birth Rate | 1 | 1997 | 28 | 0.130 |
Why?
| | User-Computer Interface | 1 | 2019 | 165 | 0.130 |
Why?
| | Family Planning Services | 1 | 1999 | 94 | 0.130 |
Why?
| | Metabolome | 1 | 2021 | 384 | 0.130 |
Why?
| | Editorial Policies | 1 | 1998 | 46 | 0.130 |
Why?
| | Censuses | 1 | 1997 | 35 | 0.130 |
Why?
| | Anxiety | 1 | 2025 | 1110 | 0.130 |
Why?
| | Treatment Outcome | 6 | 2026 | 11695 | 0.130 |
Why?
| | Pregnancy Rate | 1 | 1997 | 69 | 0.130 |
Why?
| | Prejudice | 1 | 1997 | 60 | 0.130 |
Why?
| | Intensive Care Units | 2 | 2023 | 916 | 0.130 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1540 | 0.130 |
Why?
| | Pregnancy in Adolescence | 1 | 1997 | 84 | 0.130 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 7 | 0.120 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 19 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2019 | 285 | 0.120 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2025 | 342 | 0.120 |
Why?
| | Developing Countries | 1 | 1999 | 318 | 0.120 |
Why?
| | Cause of Death | 2 | 2018 | 472 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2021 | 412 | 0.120 |
Why?
| | Trauma Centers | 2 | 2016 | 462 | 0.120 |
Why?
| | Caregivers | 1 | 2024 | 1049 | 0.120 |
Why?
| | Oxygen | 1 | 2001 | 995 | 0.120 |
Why?
| | Medical Staff, Hospital | 1 | 2016 | 80 | 0.110 |
Why?
| | Hyperlipidemias | 1 | 2016 | 122 | 0.110 |
Why?
| | Cell Nucleus | 1 | 2019 | 619 | 0.110 |
Why?
| | Retinal Diseases | 1 | 2016 | 101 | 0.110 |
Why?
| | Abortion, Induced | 1 | 1997 | 110 | 0.110 |
Why?
| | Women's Health | 1 | 1997 | 310 | 0.110 |
Why?
| | Interviews as Topic | 1 | 2019 | 901 | 0.110 |
Why?
| | Comparative Effectiveness Research | 1 | 2016 | 170 | 0.110 |
Why?
| | Organizational Culture | 1 | 2016 | 162 | 0.110 |
Why?
| | Quality Improvement | 1 | 2023 | 1291 | 0.100 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 49 | 0.100 |
Why?
| | Military Personnel | 1 | 2001 | 747 | 0.100 |
Why?
| | Area Under Curve | 1 | 2014 | 331 | 0.100 |
Why?
| | Deglutition | 1 | 2013 | 72 | 0.090 |
Why?
| | Rural Population | 1 | 1997 | 650 | 0.090 |
Why?
| | Exercise | 1 | 2024 | 2201 | 0.090 |
Why?
| | Patient Safety | 1 | 2016 | 349 | 0.090 |
Why?
| | Mass Screening | 1 | 2021 | 1348 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 1998 | 1416 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1358 | 0.090 |
Why?
| | Cyclophosphamide | 1 | 2012 | 266 | 0.090 |
Why?
| | Mycophenolic Acid | 1 | 2012 | 120 | 0.090 |
Why?
| | Incidence | 2 | 2026 | 2883 | 0.090 |
Why?
| | Cyclosporine | 1 | 2012 | 265 | 0.090 |
Why?
| | Medical Audit | 1 | 2011 | 77 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1915 | 0.090 |
Why?
| | Time Factors | 4 | 2019 | 7183 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2016 | 693 | 0.080 |
Why?
| | Feasibility Studies | 2 | 2026 | 1095 | 0.080 |
Why?
| | Gastrostomy | 1 | 2012 | 130 | 0.080 |
Why?
| | Tracheostomy | 1 | 2012 | 142 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2023 | 3608 | 0.080 |
Why?
| | Utah | 2 | 2025 | 81 | 0.080 |
Why?
| | Colorado | 3 | 2025 | 4564 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8279 | 0.070 |
Why?
| | Interleukin-1 | 1 | 2012 | 961 | 0.070 |
Why?
| | Age Factors | 3 | 2014 | 3335 | 0.070 |
Why?
| | Patient Transfer | 1 | 2011 | 206 | 0.070 |
Why?
| | Gestational Age | 1 | 2010 | 975 | 0.060 |
Why?
| | Guideline Adherence | 1 | 2011 | 589 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2584 | 0.060 |
Why?
| | Ventilators, Mechanical | 1 | 2025 | 70 | 0.060 |
Why?
| | Research | 2 | 1999 | 431 | 0.060 |
Why?
| | Tidal Volume | 1 | 2025 | 111 | 0.060 |
Why?
| | Infusions, Intravenous | 1 | 2026 | 423 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 6053 | 0.050 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.050 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 125 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 80 | 0.050 |
Why?
| | Sepsis-Associated Encephalopathy | 1 | 2024 | 1 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2021 | 2947 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2024 | 205 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 207 | 0.050 |
Why?
| | Heart Rate | 2 | 2025 | 855 | 0.050 |
Why?
| | Ritonavir | 1 | 2023 | 75 | 0.050 |
Why?
| | Health Facilities | 1 | 2023 | 85 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2022 | 87 | 0.050 |
Why?
| | Semicircular Canals | 1 | 1982 | 37 | 0.050 |
Why?
| | Health Insurance Portability and Accountability Act | 1 | 2022 | 13 | 0.050 |
Why?
| | Urban Population | 1 | 2025 | 491 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2026 | 337 | 0.040 |
Why?
| | Streptococcal Infections | 1 | 2024 | 169 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2023 | 147 | 0.040 |
Why?
| | Biochemical Phenomena | 1 | 2001 | 9 | 0.040 |
Why?
| | Sinusitis | 1 | 2024 | 229 | 0.040 |
Why?
| | Intelligence Tests | 1 | 2021 | 56 | 0.040 |
Why?
| | Data Accuracy | 1 | 2022 | 65 | 0.040 |
Why?
| | Treatment Failure | 1 | 2022 | 365 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2001 | 1311 | 0.040 |
Why?
| | Time | 1 | 2001 | 86 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 48 | 0.040 |
Why?
| | Health Policy | 1 | 2024 | 401 | 0.040 |
Why?
| | Government Regulation | 1 | 2021 | 38 | 0.040 |
Why?
| | Ethics Committees, Research | 1 | 2021 | 41 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 433 | 0.040 |
Why?
| | Health Resources | 1 | 2022 | 130 | 0.040 |
Why?
| | Pregnancy | 3 | 1999 | 7191 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 76 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 117 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2021 | 143 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 398 | 0.040 |
Why?
| | Attention | 1 | 2023 | 458 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 27 | 0.040 |
Why?
| | Women, Working | 1 | 1999 | 12 | 0.040 |
Why?
| | Database Management Systems | 1 | 1999 | 50 | 0.040 |
Why?
| | Delphi Technique | 1 | 2020 | 331 | 0.040 |
Why?
| | Ethics | 1 | 1998 | 4 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 489 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 1327 | 0.030 |
Why?
| | Southeastern United States | 1 | 1997 | 37 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2022 | 732 | 0.030 |
Why?
| | South Africa | 1 | 1999 | 261 | 0.030 |
Why?
| | Emotions | 1 | 2023 | 578 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 475 | 0.030 |
Why?
| | North Carolina | 1 | 1997 | 128 | 0.030 |
Why?
| | Body Composition | 1 | 2001 | 706 | 0.030 |
Why?
| | Patient Admission | 1 | 2019 | 218 | 0.030 |
Why?
| | Neuroendocrine Tumors | 1 | 2019 | 114 | 0.030 |
Why?
| | United Kingdom | 1 | 1998 | 338 | 0.030 |
Why?
| | Biomedical Research | 1 | 2023 | 710 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 781 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2001 | 2029 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2022 | 988 | 0.030 |
Why?
| | Fundus Oculi | 1 | 2016 | 89 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 56 | 0.030 |
Why?
| | Health Care Surveys | 1 | 1997 | 539 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 1997 | 268 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 308 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 727 | 0.030 |
Why?
| | Odds Ratio | 2 | 2014 | 1077 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 145 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1423 | 0.030 |
Why?
| | Coroners and Medical Examiners | 1 | 1994 | 8 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1403 | 0.030 |
Why?
| | Health Education | 1 | 1997 | 358 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1195 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1786 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2014 | 25 | 0.030 |
Why?
| | Death Certificates | 1 | 1994 | 32 | 0.030 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 1993 | 3 | 0.030 |
Why?
| | Receptors, Neuropeptide | 1 | 1993 | 6 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2014 | 143 | 0.030 |
Why?
| | Risk Adjustment | 1 | 2014 | 85 | 0.020 |
Why?
| | Societies, Medical | 1 | 1997 | 887 | 0.020 |
Why?
| | Program Evaluation | 1 | 1997 | 949 | 0.020 |
Why?
| | DNA, Complementary | 1 | 1993 | 277 | 0.020 |
Why?
| | Cognition | 1 | 2021 | 1269 | 0.020 |
Why?
| | Cross Infection | 1 | 2015 | 262 | 0.020 |
Why?
| | Public Health | 1 | 1997 | 566 | 0.020 |
Why?
| | Sex Factors | 2 | 2014 | 2114 | 0.020 |
Why?
| | Decision Making | 1 | 1998 | 980 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 427 | 0.020 |
Why?
| | Swine | 1 | 1993 | 833 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1385 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2019 | 927 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 529 | 0.020 |
Why?
| | Goals | 1 | 2011 | 184 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 1997 | 1099 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3082 | 0.020 |
Why?
| | Triage | 1 | 2011 | 249 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2011 | 335 | 0.020 |
Why?
| | Pyridoxine | 1 | 1988 | 37 | 0.020 |
Why?
| | Premenstrual Syndrome | 1 | 1988 | 33 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 1988 | 198 | 0.020 |
Why?
| | Hemorrhage | 1 | 1988 | 809 | 0.010 |
Why?
| | Physical Stimulation | 1 | 1982 | 68 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 1982 | 69 | 0.010 |
Why?
| | Reflex | 1 | 1982 | 69 | 0.010 |
Why?
| | Nausea | 1 | 1982 | 111 | 0.010 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 1999 | 14 | 0.010 |
Why?
| | Nutrition Surveys | 1 | 1999 | 282 | 0.010 |
Why?
| | Cattle | 1 | 1999 | 1000 | 0.010 |
Why?
| | Iowa | 1 | 1994 | 32 | 0.010 |
Why?
| | Receptors, Calcitonin | 1 | 1993 | 3 | 0.010 |
Why?
| | Receptors, Vasoactive Intestinal Peptide | 1 | 1993 | 3 | 0.010 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 1993 | 19 | 0.010 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 1993 | 7 | 0.010 |
Why?
| | Homicide | 1 | 1994 | 68 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1993 | 140 | 0.010 |
Why?
| | Bias | 1 | 1994 | 202 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1993 | 368 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1993 | 396 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1993 | 209 | 0.010 |
Why?
| | Species Specificity | 1 | 1993 | 574 | 0.010 |
Why?
| | Prevalence | 1 | 1999 | 2836 | 0.010 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1993 | 233 | 0.010 |
Why?
| | Transfection | 1 | 1993 | 940 | 0.010 |
Why?
| | Accidental Falls | 1 | 1994 | 222 | 0.010 |
Why?
| | Base Sequence | 1 | 1993 | 2191 | 0.000 |
Why?
| | Amino Acid Sequence | 1 | 1993 | 2157 | 0.000 |
Why?
| | Captopril | 1 | 1988 | 11 | 0.000 |
Why?
| | Drug Evaluation | 1 | 1988 | 79 | 0.000 |
Why?
| | Arginine Vasopressin | 1 | 1988 | 44 | 0.000 |
Why?
| | Molecular Sequence Data | 1 | 1993 | 2931 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1988 | 321 | 0.000 |
Why?
| | Hypotension | 1 | 1988 | 126 | 0.000 |
Why?
| | Animals | 3 | 1999 | 38109 | 0.000 |
Why?
| | Protein Binding | 1 | 1993 | 2276 | 0.000 |
Why?
| | Suicide | 1 | 1994 | 720 | 0.000 |
Why?
| | Drug Therapy, Combination | 1 | 1988 | 1048 | 0.000 |
Why?
| | Gene Expression Regulation | 1 | 1993 | 2609 | 0.000 |
Why?
| | Rats | 1 | 1988 | 5614 | 0.000 |
Why?
|
|
Bennett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|